Found: 6
Select item for more details and to access through your institution.
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E5, doi. 10.1002/ajh.26010
- By:
- Publication type:
- Article
Update on the current and future use of CAR‐T to treat multiple myeloma.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 4, p. 493, doi. 10.1111/ejh.14145
- By:
- Publication type:
- Article
Severe obesity does not worsen transplantation outcome in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e292, doi. 10.1016/j.clml.2019.09.479
- By:
- Publication type:
- Article
Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e115, doi. 10.1016/j.clml.2019.09.191
- By:
- Publication type:
- Article
Dedifferentiated Liposarcoma: Systemic Therapy Options.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Management of Relapsed and Refractory Multiple Myeloma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 4, p. 164, doi. 10.46883/2023.25920991
- By:
- Publication type:
- Article